News
A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
France 24 on MSN18h
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
This follows "hundreds of reports of acute and chronic pancreatitis from people who have taken drugs such as Mounjaro, ...
TMates Weightloss Semaglutide reviews reveal how users are losing weight with this telehealth prescription service—see if it ...
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...
Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results